secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-08-19T23:59:59+00:00
Accession:  0001178913-25-002985
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion Therapeutics shareholders approve 6x increase in authorized shares to 9M
--------------------------------------------------------------------------------

- Authorized capital raised from US$20,000 (1,481,482 shares) to US$121,500 (9,000,000 shares).
- Vote results: 699,871 for (59.8%), 470,828 against (40.2%), 289,225 abstentions.
- Meeting originally Aug 12, 2025, reconvened Aug 19 after no quorum; 16.8% of shares present constituted quorum under Articles.
- Memorandum Amendment filed and effective in Cayman Islands on August 19, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/0001178913-25-002985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/zk2533680.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-002985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer